After PhRMA loss, AstraZeneca's challenge to IRA price negotiations is rejected
After PhRMA loss, AstraZeneca's challenge to IRA price negotiations is rejected kdunleavy Fri, 03/01/2024 - 14:48
After PhRMA loss, AstraZeneca's challenge to IRA price negotiations is rejected kdunleavy Fri, 03/01/2024 - 14:48
Moderna lays off parts of manufacturing team after resizing COVID footprint mbayer Fri, 03/01/2024 - 11:47
Ahead of strategy reveal, Bayer taps activist investor Jeffrey Ubben for board seat zbecker Fri, 03/01/2024 - 11:36
As Imbruvica stumbles, BeiGene's Brukinsa steps up with FDA nod in follicular lymphoma aliu Fri, 03/01/2024 - 10:32
With Sanofi left as the lone supplier of tetanus shots in the US, CDC warns of shortage kdunleavy Fri, 03/01/2024 - 10:30
Kyowa Kirin plans $200M plant in NC, where it'll hire 100-plus new employees fkansteiner Fri, 03/01/2024 - 09:22
CAR-T boxed warnings: What comes next? aellison Fri, 03/01/2024 - 08:47
Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030 aliu Thu, 02/29/2024 - 16:39